Subject:
Fwd: [en] IACM-Bulletin of 29 August 2010
From:
troberts38@comcast.netDate:
Sun, 29 Aug 2010 19:04:47 +0000 (UTC)
To:
MAPS Forum <
maps_forum@maps.org>
-----
info@cannabis-med.org wrote:
--------------------------------------------------------
IACM-Bulletin of 29 August 2010
--------------------------------------------------------
* Science: Production of THC by genetically modified bacteria
*Germany: Changes of the narcotics law to allow for the approval of
Sativex intended
* Germany: Federal Institute for Drugs and Medical Devices rejects
application for self-cultivation of cannabis for medicinal purposes
* USA/The Netherlands: The cannabis grower Bedrocan goes
international and intends to get approval by US health authorities in
the long run
1.
Science: Production of THC by genetically modified bacteria
Scientists of the Technical University of Dortmund, Germany, have
genetically manipulated bacteria in a manner that allows them to
produce the main psychoactive compound of cannabis. This
procedure for the production of THC (dronabinol) is thought to be
less laborious and therefore cheaper in comparison to the currently
used procedure in Germany, said Oliver Kayser of the university on
17 August.
To date, dronabinol has been produced from fibre hemp in
Germany. Cannabidiol (CBD) is extracted from this hemp and
converted into THC. Chemical extraction from THC-rich drug hemp
is not allowed in Germany. The synthetic manufacture of dronabinol
would also be costly in comparison to the new procedure. Kayser
is anticipating production costs with the new procedure of only
about 2,500 Euros per kilogram of THC. E. coli bacteria with
isolated genes are responsible for the production of THC in the
plant are used. Together with a pharmaceutical company, the
University of Dortmund is planning the foundation of a company for
THC production.
More at:
http://derstandard.at/1281829392202/Tetrahydrocannabinol- Bakterien-koennen-ohne-viel-Aufwand-Cannabis-Wirkstoff-
produzieren
(Source: Standard of 17 August 2010)
